Ahzantive (Klinge Biopharma GmbH)

by Pelican Press
0 minutes read

Ahzantive (Klinge Biopharma GmbH)

Ahzantive (Active substance: Aflibercept) – Centralised – Authorisation – Commission Decision (2025) 262 of Mon, 13 Jan 2025 – European Medicines Agency (EMA) procedure number: EMEA/H/C/006607/0000


Source link

#Ahzantive #Klinge #Biopharma #GmbH

You may also like